Targeted
Therapy
Targeted therapy is a
type of treatment that uses drugs or other substances to identify
and attack specific cancer cells without harming normal cells.
Erlotinib (Tarceva®) is a targeted therapy that was approved
in combination with gemcitabine (Gemzar®) in November 2005 for
the treatment of pancreatic cancer.
Most other targeted therapies
are still in clinical studies. Once researchers better understand
the growth and spread of tumors, they will be better able to identify
patients who may benefit from targeted therapies.
Below you will find links
to information about some targeted therapies currently being studied
for the treatment of pancreatic cancer.
FDA Consumer Information Sheets (for some drugs):
Consumer
Information Sheet - Avastin
Consumer
Information Sheet - Erbitux
|
